Damon Runyon
We fund high-risk, high-reward cancer research
FDA approves novel treatment for acute myeloid leukemia | New Discoveries
FDA approves novel treatment for acute myeloid leukemia | New Discoveries
Acute myeloid leukemia (AML) is diagnosed in more than 20,000 people in the U.S. each year, and the five-year survival rate remains around 30%. For patients whose disease is driven by mutations in the gene NPM1, the most common mutation in adult AML, treatment options have long been limited.
Damon Runyon Cancer Research Foundation awards $4.5M to top young scientists - Honors and Awards
Damon Runyon Cancer Research Foundation awards $4.5M to top young scientists - Honors and Awards
The Damon Runyon Cancer Research Foundation has named 13 new Damon Runyon Fellows, exceptional postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading senior investigators. The prestigious, four-year Fellowship encourages the nation’s most promising young scientists to pursue careers in cancer research by providing them with independent funding ($300,000 total) to investigate cancer causes, mechanisms, therapies, and prevention.
Damon Runyon scientists gather for 2026 Accelerating Cancer Cures Symposium
Damon Runyon scientists gather for 2026 Accelerating Cancer Cures Symposium
Damon Runyon scientists and industry partners gathered on Tuesday, March 24, for the 2026 Accelerating Cancer Cures Research Symposium, hosted by Amgen in Cambridge, Massachusetts.
A hidden weakness in pancreatic cancer cells | New Discoveries
A hidden weakness in pancreatic cancer cells | New Discoveries
Cancer drugs often target a molecule that cancer cells rely on for survival but, crucially, healthy cells do not. When they are first identified, this type of molecule is known as a therapeutic vulnerability—and what previously made the cancer cell especially fit now makes it an easier target.
Damon Runyon Cancer Research Foundation awards $3.2M to innovative early-career scientists - Honors and Awards
Damon Runyon Cancer Research Foundation awards $3.2M to innovative early-career scientists - Honors and Awards
The Damon Runyon Cancer Research Foundation has announced eight recipients of the 2026 Damon Runyon-Rachleff Innovation Award, established to support high-risk, high-reward ideas with the potential to significantly impact the prevention, diagnosis, or treatment of cancer. Five extraordinary early-career researchers will receive initial grants of $400,000 over two years, and each will have the opportunity to receive two additional years of funding (for a potential total of $800,000).
A potential breakthrough in treating RAS-driven cancers
A potential breakthrough in treating RAS-driven cancers
Cancers caused by mutations in the RAS gene family—which include pancreatic, colorectal, lung, skin, and ovarian cancers, among others—have thwarted drug development efforts for decades.
Creative Ways to Back Young Scientists: Andy Rachleff and Yung Lie on The Long Run - TimmermanReport.com
Creative Ways to Back Young Scientists: Andy Rachleff and Yung Lie on The Long Run - TimmermanReport.com
Yung Lie and Andy Rachleff are today’s guests on The Long Run. Yung is the president and CEO of the Damon Runyon Cancer Research Foundation, based in New York. Andy is the board chair. Andy was one of the founding partners of Benchmark Capital, the prominent Silicon Valley VC firm, and today is the chairman... Read More
Damon Runyon awards $4.2 million to clinical cancer research
Damon Runyon awards $4.2 million to clinical cancer research
The Damon Runyon Cancer Research Foundation has named five new Damon Runyon Clinical Investigators. The recipients of this prestigious award are outstanding, early-career physician-scientists conducting patient-oriented cancer research at major research centers under the mentorship of the nation's leading scientists and clinicians.
Damon Runyon Cancer Research Foundation invests nearly $1.4 million to support physician-scientists
Damon Runyon Cancer Research Foundation invests nearly $1.4 million to support physician-scientists
A new approach to targeted therapy
A new approach to targeted therapy
In cancer treatment, “targeted therapies” refer to drugs that identify and attack specific proteins in cancer cells that help them survive and grow, while leaving normal cells alone. Due to their specificity, targeted therapies tend to be less toxic than chemotherapy or radiation therapies. Often, they take the form of small molecule inhibitors, which bind to the cancer-promoting proteins and disable them. Unfortunately, however, small molecule inhibitors only work for a subset of cancers.
A new explanation for sex differences in cancer
A new explanation for sex differences in cancer
Translocation renal cell carcinoma (tRCC) is a type of kidney cancer that arises when a gene called TFE3 on the X chromosome fuses with another gene on either the X chromosome or an autosome, as non-sex chromosomes are called. Unlike most kidney cancers, tRCC occurs mainly in female individuals, though why this is the case has never been clear. Now, a new study from Damon Runyon-Rachleff Innovator Srinivas R.
Timmerman Traverse for Damon Runyon Cancer Research Foundation
Timmerman Traverse for Damon Runyon Cancer Research Foundation
Damon Runyon Cancer Research Foundation and St. Jude Children’s Research Hospital invest $1.8 million in childhood cancer research
Damon Runyon Cancer Research Foundation and St. Jude Children’s Research Hospital invest $1.8 million in childhood cancer research
Support Damon Runyon on World Cancer Day
Support Damon Runyon on World Cancer Day
Damon Runyon Cancer Research Foundation awards $3.2M to innovative young scientists
Damon Runyon Cancer Research Foundation awards $3.2M to innovative young scientists
The Damon Runyon Cancer Research Foundation has announced eight recipients of the 2025 Damon Runyon-Rachleff Innovation Award, established to support high-risk, high-reward ideas with the potential to significantly impact the prevention, diagnosis, or treatment of cancer. Five extraordinary early-career researchers will receive initial grants of $400,000 over two years, and each will have the opportunity to receive two additional years of funding (for a potential total of $800,000).
All gifts of any size fully matched between now and midnight! Donate today.
All gifts of any size fully matched between now and midnight! Donate today.
Slowing the clock on aging stem cells
Slowing the clock on aging stem cells
Blood stem cells, like all living things, lose their regenerative capacity with age. Because blood stem cells generate not only blood but all the cells in our immune system, age-related dysfunction can lead to a plethora of systemic issues in older adults, including blood cancer. There is, of course, no stopping time. But according to a new study from researchers at the Columbia Stem Cell Initiative, including Damon Runyon Fellow James Swann, VetMB, DPhil, there may be a way to slow down the clock.
One man’s mission to revive a forgotten, life-saving cancer drug
One man’s mission to revive a forgotten, life-saving cancer drug
Jake’s Story - The Jake Wetchler Foundation
Jake’s Story - The Jake Wetchler Foundation
The Jake Wetchler Foundation is founded in remembrance of our son, Jake, and all children fighting against cancer. Jake had Hodgkin's lymphoma disease but lost his life to Acute Myeloid Leukemia. Even though Jake did not survive, his ideals inspired us to continue the fight. Learn about his story.
Damon Runyon Cancer Research Foundation awards $4.8 million to exceptional early-career scientists
Damon Runyon Cancer Research Foundation awards $4.8 million to exceptional early-career scientists
Damon Runyon Cancer Research Foundation awards $5.2 million to top clinical investigators
Damon Runyon Cancer Research Foundation awards $5.2 million to top clinical investigators
New blood test to detect aggressive form of prostate cancer
New blood test to detect aggressive form of prostate cancer
Damon Runyon announces inaugural class of SPARK Scholars
Damon Runyon announces inaugural class of SPARK Scholars
“Virtual biopsy” may transform how we diagnose skin cancer
“Virtual biopsy” may transform how we diagnose skin cancer
Damon Runyon Cancer Research Foundation announces four recipients of 2024 Physician-Scientist Training Award
Damon Runyon Cancer Research Foundation announces four recipients of 2024 Physician-Scientist Training Award
Get Involved | Damon Runyon
Get Involved | Damon Runyon
Damon Runyon Cancer Research Foundation awards $3.2M to innovative early-career scientists
Damon Runyon Cancer Research Foundation awards $3.2M to innovative early-career scientists
2024 Timmerman Traverse raises over $1M for cancer research
2024 Timmerman Traverse raises over $1M for cancer research
Inaugural class of Damon Runyon–St. Jude Pediatric Cancer Research Fellows announced
Inaugural class of Damon Runyon–St. Jude Pediatric Cancer Research Fellows announced
Damon Runyon launches SPARK post-baccalaureate research internship
Damon Runyon launches SPARK post-baccalaureate research internship
Make a gift
Make a gift
Reviving an old hypothesis about chromosomes and cancer
Reviving an old hypothesis about chromosomes and cancer
Potential new targeted therapy for a rare but lethal cancer
Potential new targeted therapy for a rare but lethal cancer
Early immunotherapy drug shows new promise against glioblastoma in mice
Early immunotherapy drug shows new promise against glioblastoma in mice
A “MAJESTIC” new way to engineer CAR T cells
A “MAJESTIC” new way to engineer CAR T cells
2024 Timmerman Traverse to benefit Damon Runyon’s cancer researchers
2024 Timmerman Traverse to benefit Damon Runyon’s cancer researchers
Damon Runyon Cancer Research Foundation awards $3.9 million to exceptional early-career scientists
Damon Runyon Cancer Research Foundation awards $3.9 million to exceptional early-career scientists
Two new clinical trials offer hope for brain cancer patients
Two new clinical trials offer hope for brain cancer patients
A new way to visualize antibody-virus data
A new way to visualize antibody-virus data
Stipend Increase
Stipend Increase
Kelly L. Bolton, MD, PhD
Kelly L. Bolton, MD, PhD
2023 Physician-Scientist Training Award
2023 Physician-Scientist Training Award
2023 Damon Runyon 5K at Yankee Stadium
2023 Damon Runyon 5K at Yankee Stadium
Damon Runyon–St. Jude Pediatric Cancer Research Fellowship
Damon Runyon–St. Jude Pediatric Cancer Research Fellowship
New immunotherapy-enhancing drug is making its way to the clinic
New immunotherapy-enhancing drug is making its way to the clinic
New discoveries support the idea that boosting the p53 gene may suppress pancreatic tumor growth
New discoveries support the idea that boosting the p53 gene may suppress pancreatic tumor growth
Exciting new research on glioblastomas
Exciting new research on glioblastomas
Support Damon Runyon
Support Damon Runyon
AmazonSmile: You shop. Amazon gives.
AmazonSmile: You shop. Amazon gives.
The work of generations: how a Nobel Prize is won
The work of generations: how a Nobel Prize is won
Support Damon Runyon on Amazon Smile
Support Damon Runyon on Amazon Smile
Click for more news!
Click for more news!
View on mobile
Explore other Linktrees
Stanley Tucci
@stanleytucci
OrelSanTour2026
@OrelSanTour2026
Kaitlyn Johnson
@missynjohnson
Remy Morimoto Park
@veggiekins
Fibs and Friends
@fibsandfriends
Substack
@substackinc
jenniferhudsonshow
@jenniferhudsonshow
gigglysquad
@gigglysquad
mateosoda
@mateosoda
Michelle Ahn
@ohtheplacesyoullgrow
previous
next
Discover more
See all
@silasalves
@candlesbyemx
@lostwithsarah6
@DyyGame
@SchenzelCommunityCenter
@Vaibhav_1482
@CHORIHOUSE
@volantinesverdes
@ecco_cine
@continueclubbkk
@monttonecarneiros
@erika2507
@sifasilajouer
@avenridge
@esucoscarazinho
@topzee.unco
@giodejesusmusic
@NowAndZenStudio
@sinfuldragon99
@wokhey.sg
@aavishkar.cse
@infokaoriparfume
@acura.ae
@sntintasoficial
@Brunolinktree
@wannajunglebar
@ymnation
@Mulherdeourooo
@minimalchicfinds
@SmeetDoshi
@Destiny_Market
@victoralexug
@pret21_ece
@our.mixed.eats
@DUOCAST
@Adrianapeccin
@stephaniemartin.music
@capkore
@bestiesinparis
@efeaxi
@RepWayneFarrin
@jadenpierce
@GamesHaven
@Jhennyphonto
@strikesanctuary1
More from Linktree
Products
Link in bio + tools
Manage your social media
Grow and engage your audience
Monetize your following
Measure your success
Templates
Marketplace
Learn
Resources
How to use Linktree
Pricing
Link in bio + tools
Link in bio
Customize your Linktree
Link shortener
Create trackable, shareable short links
QR code generator
Turn links into scannable QR codes
Canva Background Editor
Import your custom designs from Canva into your profile
Linktree for every social platform
Grow and engage your audience everywhere
Instagram
TikTok
LinkedIn
X
Manage your social media
Schedule and auto-post
Hands-free, hassle-free social media planning
Instagram auto reply
Automated replies and DMs triggered by comments
AI content & caption generator
Instant AI-powered post ideas and captions
Hashtag generator
Trending hashtag suggestions for better reach
Social integration for every social platform
Plan, auto post, and share across all platforms
Instagram
TikTok
Facebook
Pinterest
LinkedIn
Threads
Youtube
Grow and engage your audience
Collect leads with contact forms
Turn visitors into subscribers
Manage and activate your audience
Organize, tag, and track contacts
Send contacts to email tools
Sync with Mailchimp, Klaviyo, Kit & more
Monetize your following
Earn with a Linktree Shop
Sell products and earn commission
Sell an online course
Create and sell your expertise easily
Host digital products
Sell digital products and build your email list
Earn by hosting sponsored links
Share brand offers and earn for every sign-up or sale
Get rewarded for growing your Linktree
Earn points, level up and unlock cash bonuses
Booked and paid, easily
Offer sessions and earn from your expertise
Measure your success
Social + link analytics
Track clicks, engagement and audience insights
Resources
Read our blog
All the latest tips, tricks and growth strategies
Success Stories
Real people, real results on Linktree
How to use Linktree
Linktree Help Centre
Get answers, guides and support
✕